Press coverage about Simulations Plus (NASDAQ:SLP) has trended somewhat negative recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Simulations Plus earned a news sentiment score of 0.00 on Accern’s scale. Accern also assigned news headlines about the technology company an impact score of 45.521962134168 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- Analysts Expect Simulations Plus, Inc. (SLP) to Post $0.10 EPS (americanbankingnews.com)
- DILIsym Services Inc., a Simulations Plus Company, Releases DILIsym® Version 7A (finance.yahoo.com)
- Simulations Plus’ (SLP) CEO Walt Woltosz on Q1 2018 Results – Earnings Call Transcript (msn.com)
- Record Revenue at Simulations Plus (sfvbj.com)
- Simulations Plus Reports First Quarter FY2018 Financial Results (finance.yahoo.com)
Simulations Plus (NASDAQ SLP) remained flat at $$16.30 on Monday. The company had a trading volume of 43,500 shares, compared to its average volume of 54,500. Simulations Plus has a one year low of $9.45 and a one year high of $17.45. The stock has a market capitalization of $281.87, a price-to-earnings ratio of 46.57 and a beta of -0.76.
Several brokerages have commented on SLP. Zacks Investment Research cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research report on Wednesday, September 20th. BidaskClub cut Simulations Plus from a “buy” rating to a “hold” rating in a research note on Wednesday, November 1st.
In other Simulations Plus news, CEO Walter S. Woltosz sold 18,500 shares of the company’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $15.78, for a total value of $291,930.00. Following the sale, the chief executive officer now directly owns 5,610,916 shares in the company, valued at $88,540,254.48. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders sold 74,000 shares of company stock valued at $1,196,025 over the last 90 days. 33.45% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: “Somewhat Negative Press Coverage Somewhat Unlikely to Affect Simulations Plus (SLP) Share Price” was originally reported by BBNS and is the sole property of of BBNS. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://baseballnewssource.com/markets/simulations-plus-slp-earning-somewhat-critical-press-coverage-report-finds/1817912.html.
Simulations Plus Company Profile
Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.